+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07540026

A Randomized Trial of Endoscopic Tranexamic Acid and Sucralfate Powder for Stopping Bleeding in Gastrointestinal Tumor Patients

Led by National Cheng-Kung University Hospital · Updated on 2026-04-20

60

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating treatments for gastrointestinal tumor bleeding, a serious condition affecting patients in Taiwan and elsewhere. This bleeding occurs due to fragile tumor blood vessels and abnormal tissue growth, making it difficult to control with standard endoscopic methods like injections, clips, or heat coagulation. The study also explores how tumor-derived exosomes containing VEGF and miR-21 may influence bleeding risk and tumor growth. The trial aims to improve bleeding control and understand the relationship between these exosomes and hemorrhage. The trial compares standard endoscopic treatment alone to standard treatment plus a spray of tranexamic acid and sucralfate powders applied directly to the bleeding tumor site. Both groups receive initial therapies such as epinephrine injection, clipping, and heat coagulation as decided by the endoscopist. The intervention group gets an additional 1.5 g of tranexamic acid powder and 3 g of sucralfate powder sprayed onto the bleeding site. After treatment, patients receive proton pump inhibitors intravenously for at least 72 hours. Immediate hemostasis is observed within minutes, and participants are monitored for bleeding recurrence over 30 days. Participants undergo endoscopic procedures, and blood and tumor tissue samples are collected to analyze tumor exosomes for VEGF and miR-21 levels. These measures help assess bleeding risk and the effectiveness of the treatment. The research team tracks immediate bleeding control and any rebleeding events within 30 days, along with other outcomes like the need for surgery or mortality. The study involves 60 patients and includes observation for safety and hospitalization duration, with the goal of advancing treatment options and bleeding risk prediction for gastrointestinal tumor bleeding.

CONDITIONS

Brief Title

Endoscopic Application of Tranexamic Acid and Sucralfate in Gastrointestinal Tumor Bleeding: A Randomized Controlled Trial

Research Team

H

Hsueh-Chien Chiang, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here